Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 20, 2026

Phenotypic Profiling of Human Stem Cell-Derived Midbrain Dopaminergic Neurons
09:21

Phenotypic Profiling of Human Stem Cell-Derived Midbrain Dopaminergic Neurons

Published on: July 7, 2023

Latent cluster analysis of ALS phenotypes identifies prognostically differing groups.

Jeban Ganesalingam1, Daniel Stahl, Lokesh Wijesekera

  • 1Department of Clinical Neuroscience, MRC Centre for Neurodegeneration Research, King's College London, Institute of Psychiatry, London, United Kingdom.

Plos One
|September 23, 2009
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma exosomal HERV-K transcripts are increased in amyotrophic lateral sclerosis.

BMC neuroscience·2026
Same author

The Motor Neuron Disease Register for England, Wales, and Northern Ireland: Protocol for a Population Register.

JMIR research protocols·2026
Same author

CYP2D6 variants in amyotrophic lateral sclerosis: an association study of risk and survival.

Brain : a journal of neurology·2026
Same author

Gut microbiota and ALS: cause, consequence or correlation? - a systematic review.

Frontiers in neuroscience·2026
Same author

Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis.

Nature genetics·2026
Same author

Digenic inheritance of mutations in SPG7 and AFG3L2 causes motor neuron and cerebellar disorders.

BMC medicine·2026

Latent cluster analysis identified five distinct amyotrophic lateral sclerosis (ALS) phenotypes that predict survival. This approach can improve patient stratification in clinical trials and research for ALS.

Area of Science:

  • Neurology
  • Biostatistics

Background:

  • Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with diverse clinical presentations.
  • The underlying disease processes for different ALS phenotypes remain unclear.
  • Objective phenotyping is crucial for advancing ALS research and clinical management.

Purpose of the Study:

  • To objectively identify distinct phenotypic groupings in amyotrophic lateral sclerosis (ALS) using latent cluster analysis.
  • To improve the phenotyping of ALS for enhanced clinical trials and research.
  • To determine if distinct ALS phenotypes correlate with different disease processes.

Main Methods:

  • Latent class cluster analysis was performed on a database of 1467 individuals with ALS.
  • Discrete clinical variables, readily available at initial appointments, were utilized.

Related Experiment Videos

Last Updated: Jun 20, 2026

Phenotypic Profiling of Human Stem Cell-Derived Midbrain Dopaminergic Neurons
09:21

Phenotypic Profiling of Human Stem Cell-Derived Midbrain Dopaminergic Neurons

Published on: July 7, 2023

  • The clinical relevance of identified phenotypic groups was assessed using Kaplan-Meier survival analysis.
  • Main Results:

    • The analysis yielded five distinct phenotypic classes of ALS.
    • These five classes demonstrated a strong predictive capability for patient survival (p<0.0001).
    • Accurate classification was achievable using only two variables: symptom onset site and time from onset to diagnosis.

    Conclusions:

    • The identified five phenotypic classes of ALS are prognostic.
    • These objective phenotypic groupings can be utilized for stratifying patients in clinical trials.
    • The classification facilitates the creation of more homogeneous groups for genetic, proteomic, and risk factor research in ALS.